Euclidean Capital LLC
data from 31/03/2026
Capitalization
Portfolio size
Portfolio performance
Portfolio performance %
Performance compared to S&P 500 (%)
Stock in Euclidean Capital LLC
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2026/03/31 | VEU | VANGUARD INTL EQUITY INDEX F | 62.09% | 243.586 M $ | 3243484 | 2024/09/30 | 4.605 M $ | 2.09 % |
| 2026/03/31 | VTV | VANGUARD INDEX FDS | 26.01% | 102.024 M $ | 520000 | 2025/12/31 | 2.709 M $ | 2.73 % |
| 2026/03/31 | INDA | ISHARES TR | 4.41% | 17.312 M $ | 369600 | 2022/12/31 | -2.665 M $ | -13.34 % |
| 2026/03/31 | ORIC | ORIC PHARMACEUTICALS INC | 3.20% | 12.536 M $ | 989410 | 2020/12/31 | 4.442 M $ | 54.89 % |
| 2026/03/31 | FHTX | FOGHORN THERAPEUTICS INC | 1.92% | 7.523 M $ | 1573761 | 2020/12/31 | -975.731 K $ | -11.48 % |
| 2026/03/31 | PMVP | PMV PHARMACEUTICALS INC | 0.83% | 3.258 M $ | 2627643 | 2020/12/31 | -26.276 K $ | -0.80 % |
| 2026/03/31 | ALEC | ALECTOR INC | 0.72% | 2.812 M $ | 1307858 | 2020/12/31 | 771.636 K $ | 37.82 % |
| 2026/03/31 | SRZN | SURROZEN INC | 0.65% | 2.555 M $ | 87696 | 2023/12/31 | 572.654 K $ | 28.89 % |
| 2026/03/31 | TNYA | TENAYA THERAPEUTICS INC | 0.18% | 703.274 K $ | 1015705 | 2021/09/30 | -19.399 K $ | -2.68 % |
| 2026/03/31 | SRZNW | SURROZEN INC | 0.00% | 2.733 K $ | 170833 | 2023/09/30 | -683.000 $ | -20.00 % |
| 2026/03/31 | RAPT | RAPT THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2025/06/30 | 0.000 $ | 0.00 % |
| 2026/03/31 | SPY | SPDR S&P 500 ETF TR | 0.00% | 0.000 $ | 0 | 2023/06/30 | 0.000 $ | 0.00 % |